138 related articles for article (PubMed ID: 1989669)
1. Photosensitising potency of structural analogues of benzoporphyrin derivative (BPD) in a mouse tumour model.
Richter AM; Waterfield E; Jain AK; Allison B; Sternberg ED; Dolphin D; Levy JG
Br J Cancer; 1991 Jan; 63(1):87-93. PubMed ID: 1989669
[TBL] [Abstract][Full Text] [Related]
2. Liposomal delivery of a photosensitizer, benzoporphyrin derivative monoacid ring A (BPD), to tumor tissue in a mouse tumor model.
Richter AM; Waterfield E; Jain AK; Canaan AJ; Allison BA; Levy JG
Photochem Photobiol; 1993 Jun; 57(6):1000-6. PubMed ID: 8367528
[TBL] [Abstract][Full Text] [Related]
3. Biodistribution of tritiated benzoporphyrin derivative (3H-BPD-MA), a new potent photosensitizer, in normal and tumor-bearing mice.
Richter AM; Cerruti-Sola S; Sternberg ED; Dolphin D; Levy JG
J Photochem Photobiol B; 1990 Apr; 5(2):231-44. PubMed ID: 2111398
[TBL] [Abstract][Full Text] [Related]
4. Mouse skin photosensitization with benzoporphyrin derivatives and Photofrin: macroscopic and microscopic evaluation.
Richter AM; Yip S; Waterfield E; Logan PM; Slonecker CE; Levy JG
Photochem Photobiol; 1991 Feb; 53(2):281-6. PubMed ID: 1826372
[TBL] [Abstract][Full Text] [Related]
5. Photosensitizing efficiency of two regioisomers of the benzoporphyrin derivative monoacid ring A (BPD-MA).
Richter AM; Jain AK; Canaan AJ; Waterfield E; Sternberg ED; Levy JG
Biochem Pharmacol; 1992 Jun; 43(11):2349-58. PubMed ID: 1610400
[TBL] [Abstract][Full Text] [Related]
6. Modified polyvinyl alcohol-benzoporphyrin derivative conjugates as phototoxic agents.
Davis N; Liu D; Jain AK; Jiang SY; Jiang F; Richter A; Levy JG
Photochem Photobiol; 1993 Apr; 57(4):641-7. PubMed ID: 8506392
[TBL] [Abstract][Full Text] [Related]
7. Biodistribution of a benzoporphyrin derivative-monoclonal antibody conjugate in A549-tumor-bearing nude mice.
Jiang FN; Richter AM; Jain AK; Levy JG; Smits C
Biotechnol Ther; 1993; 4(1-2):43-61. PubMed ID: 8374512
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of contact hypersensitivity with different analogs of benzoporphyrin derivative.
Simkin GO; King DE; Levy JG; Chan AH; Hunt DW
Immunopharmacology; 1997 Oct; 37(2-3):221-30. PubMed ID: 9403341
[TBL] [Abstract][Full Text] [Related]
9. In vitro evaluation of phototoxic properties of four structurally related benzoporphyrin derivatives.
Richter AM; Waterfield E; Jain AK; Sternberg ED; Dolphin D; Levy JG
Photochem Photobiol; 1990 Sep; 52(3):495-500. PubMed ID: 2284343
[TBL] [Abstract][Full Text] [Related]
10. Photodynamic therapy of squamous cell carcinoma. An evaluation of a new photosensitizing agent, benzoporphyrin derivative and new photoimmunoconjugate.
Hemming AW; Davis NL; Dubois B; Quenville NF; Finley RJ
Surg Oncol; 1993; 2(3):187-96. PubMed ID: 8252208
[TBL] [Abstract][Full Text] [Related]
11. Time-dependent biodistribution of tetra(m-hydroxyphenyl)chlorin and benzoporphyrin derivative monoacid ring A in the hamster model: comparative fluorescence microscopy study.
Andrejevic Blant S; Ballini JP; van den Bergh H; Fontolliet C; Wagnières G; Monnier P
Photochem Photobiol; 2000 Mar; 71(3):333-40. PubMed ID: 10732452
[TBL] [Abstract][Full Text] [Related]
12. Calculation of singlet oxygen dose using explicit and implicit dose metrics during benzoporphyrin derivative monoacid ring A (BPD-MA)-PDT in vitro and correlation with MLL cell survival.
Weston MA; Patterson MS
Photochem Photobiol; 2011; 87(5):1129-37. PubMed ID: 21575000
[TBL] [Abstract][Full Text] [Related]
13. Spectral characterization of the benzoporphyrin derivative monoacid ring-A photoproduct formed in fetal calf solutions during irradiation with 694 nm continuous-wave radiation.
Gillies R; Kollias N; Hasan T; Diddens H
J Photochem Photobiol B; 1996 Mar; 33(1):87-90. PubMed ID: 8786464
[TBL] [Abstract][Full Text] [Related]
14. High efficiency of benzoporphyrin derivative in the photodynamic therapy of pigmented malignant melanoma.
Busetti A; Soncin M; Jori G; Rodgers MA
Br J Cancer; 1999 Feb; 79(5-6):821-4. PubMed ID: 10070875
[TBL] [Abstract][Full Text] [Related]
15. Evidence for low-density lipoprotein receptor-mediated uptake of benzoporphyrin derivative.
Allison BA; Pritchard PH; Levy JG
Br J Cancer; 1994 May; 69(5):833-9. PubMed ID: 8180011
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of benzoporphyrin derivative, a photosensitizer, in selective destruction of leukemia cells using a murine tumor model.
Jamieson C; Richter A; Levy JG
Exp Hematol; 1993 May; 21(5):629-34. PubMed ID: 8513863
[TBL] [Abstract][Full Text] [Related]
17. Clinical pharmacokinetics of anti-angiogenic photodynamic therapy with benzoporphyrin derivative monoacid ring-A in dogs having naturally occurring neoplasms.
Osaki T; Hoshino S; Hoshino Y; Takagi S; Okumura M; Kadosawa T; Fujinaga T
J Vet Med A Physiol Pathol Clin Med; 2006 Mar; 53(2):108-12. PubMed ID: 16466464
[TBL] [Abstract][Full Text] [Related]
18. Intracellular localization and concentration as well as photodynamic effects of benzoporphyrin derivative monoacid ring A in four types of rodent tumor cells.
Osaki T; Takagi S; Hoshino Y; Okumura M; Fujinaga T
Cancer Lett; 2006 Nov; 243(2):281-92. PubMed ID: 16412570
[TBL] [Abstract][Full Text] [Related]
19. Dye-mediated photolysis is capable of eliminating drug-resistant (MDR+) tumor cells.
Lemoli RM; Igarashi T; Knizewski M; Acaba L; Richter A; Jain A; Mitchell D; Levy J; Gulati SC
Blood; 1993 Feb; 81(3):793-800. PubMed ID: 8427970
[TBL] [Abstract][Full Text] [Related]
20. The plasma distribution of benzoporphyrin derivative and the effects of plasma lipoproteins on its biodistribution.
Allison BA; Pritchard PH; Richter AM; Levy JG
Photochem Photobiol; 1990 Sep; 52(3):501-7. PubMed ID: 2284344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
